Our analysis identified 48 genes coding for cell surface proteins that were not previously described as mutated in primary colorectal tumors in the TCGA database [5], including mutations in SEMA4C and FGFRL1 which have not been previously considered as potential therapeutic targets for colorectal cancer. This evidence concerns the gene FGFRL1 and colorectal cancer.